Androgen Deprivation in LNCaP Prostate Tumour Xenografts Induces Vascular Changes and Hypoxic Stress, Resulting in Promotion of Epithelial-To-Mesenchymal Transition

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2016.29
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

IKK Inhibitor Suppresses Epithelial-Mesenchymal Transition and Induces Cell Death in Prostate Cancer

Oncology Reports
MedicineCancer ResearchOncology
2016English

Role of Epithelial Mesenchymal Transition in Prostate Tumorigenesis

Current Pharmaceutical Design
Drug DiscoveryPharmacology
2015English

Epithelial-Mesenchymal Transition in Prostate Cancer: An Overview

Oncotarget
Oncology
2017English

Epithelial-Mesenchymal Transition Induces Endoplasmic-Reticulum-Stress Response in Human Colorectal Tumor Cells

PLoS ONE
Multidisciplinary
2014English

Interleukin-6 Induces Epithelial-Mesenchymal Transition in Breast Cancer Cells

Gaceta Mexicana de Oncolog�a
2019English

Reimbursement Cuts and Changes in Urologist Use of Androgen Deprivation Therapy for Prostate Cancer

BMC Urology
MedicineReproductive MedicineUrology
2015English

Atorvastatin and Celecoxib in Combination Inhibits the Progression of Androgen-Dependent LNCaP Xenograft Prostate Tumors to Androgen Independence

Cancer Prevention Research
MedicineCancer ResearchOncology
2010English

Afadin Downregulation by Helicobacter Pylori Induces Epithelial to Mesenchymal Transition in Gastric Cells

Frontiers in Microbiology
Microbiology
2018English

Androgen Upregulates the Palmitoylation of eIF3L in Human Prostate LNCaP Cells

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy